Published online Sep 11, 2013.
https://doi.org/10.3348/jksr.2013.69.3.243
Cumulative Radiation Exposures during Diagnosis and Treatments with Diagnostic Radiology Tools: In Patient with Hepatocellular Carcinoma
Abstract
Purpose
To evaluate the cumulative radiation dose for diagnosis and treatment with diagnostic radiology tools for patients with hepatocellular carcinoma.
Materials and Methods
Cumulative radiation dose of 98 patients with hepatocellular carcinoma were examined by diagnostic CT, CT for follow-up, once or repeated transarterial chemoembolization (TACE), and X-ray examinations. Thus, we calculated the total cumulative effective doses per patient.
Results
The mean follow-up periods were 85 (51-102) weeks. A total of 565 CT scans, 262 TACEs, and 1679 X-ray examinations were enrolled. Cumulative effective dose values per person of 91.4 ± 50.6 (8.4-244.7) mSv, 49.2 ± 44.7 (5.3-247.6) mSv, and 3.6 ± 4.7 (0.02-22.04) mSv were measured for CT, TACE, and X-ray examinations. Total cumulative effective dose values per person were measured as 144.2 ± 87.4 (15.4-513.5) mSv.
Conclusion
The patient who underwent TACE are exposed to pretty high dose radiations, thus, significant efforts to reduce the radiation dose are necessary.
Fig. 1
Note.-TACE = transarterial chemoembolization
Box plot shows cumulative effective dose for each examinations and total cumulative effective dose. Data points (**) are extremes and are greater than 1.5 times the interquartile range above each box.
Table 1
Number of Each Examination per a Person
Table 2
Statistics of Effective Dose Using DLP during CT and Cumulative DLP
Table 3
Statistics of Procedure Time and Effective Dose Using DAP during TACE
Table 4
Total Effective Dose of Each X-Ray Examinations
Table 5
Individual Cumulative Effective Dose (mSv)
This paper was supported by a research grant from the General Electric Healthcare, 2010.
References
-
Lee W. Current status of medical radiation exposure and regulation efforts. J Korean Med Assoc 2011;54:1248–1252.
-
-
Lee SY, Lim HS, Han MS. The Evaluation of patients' radiation dose during TACE of interventional radiology. J Radiol Sci Technol 2011;34:209–214.
-
-
Health Insurance Review & Assessment Service. 2005 National health insurance statistical yearbook. Seoul: Health Insurance Review & Assessment Service; 2006.
-
-
ICRP. 1990 Recommendations of the International Commission on Radiological Protection. ICRP publication 60. Stockholm, Sweden: ICRP; 1991.
-
-
ICRP. The 2007 recommendations of the International Commission on Radiological Protection. ICRP publication 103. Stockholm, Sweden: ICRP; 2007.
-
-
Valentin J. Avoidance of radiation injuries from medical interventional procedures. Ann ICRP 2000;30:7–67.
-
-
Chung JW. Korea Food & Drug Administration. In: Evaluation of patient dose in interventional radiology. Seoul: Korea Food & Drug Administration; 2007.
-
-
National Research Council (US). Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington DC: National Academies Press; 2006.
-
-
International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation: part 1. X- and gamma-radiation and neutrons. Lyon: International Agency for Research on Cancer; 2000.
-
-
United Nations Scientific Committee on the Effects of Atomic Radiation. Effect of ionizing radiation: UNSCEAR 2006 report to the general assembly with scientific annexes. Vienna: United Nations; 2006.
-
-
Valentin J. Low-dose extrapolation of radiation-related cancer risk. Ann ICRP 2005;35:1–140.
-
-
Jung SE. Korea Food & Drug Administration. In: Evaluation study of patient radiation dose in CT. Seoul: Korea Food & Drug Administration; 2008.
-
-
Park MY, Jung SE. CT radiation dose and radiation reduction strategies. J Korean Med Assoc 2011;54:1262–1268.
-
-
Hidajat N, Mäurer J, Schröder RJ, Nunnemann A, Wolf M, Pauli K, et al. Relationships between physical dose quantities and patient dose in CT. Br J Radiol 1999;72:556–561.
-
-
U.S. Food and Drug Administration. Safety Investigation of CT Brain Perfusion Scans. [update 2010 Sep 11]. [accessed 2012 Sep 28].Available from: http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm185898.htm.
-
-
Kang SJ. National Institute of Food and Drug Safety Evaluation. In: Guideline for optimization and justification of CT. Cheongwon: Korea Food & Drug Administration; 2012.
-
-
Jeong WK. Radiation exposure and its reduction in the fluoroscopic examination and fluoroscopy-guided interventional radiology. J Korean Med Assoc 2011;54:1269–1276.
-